Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The Joint Commission Journal on Quality Improvement
|
March 1, 1997
Development of performance measures for seven chronic diseases. Health Outcomes Work Group of the Pharmaceutical Research and Manufacturers of America
J G Kotsanos
The New England Journal of Medicine
|
January 12, 1995
Cost-effectiveness analyses
H Tilson, J G Kotsanos
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Panel 3: methodological issues in conducting pharmacoeconomic evaluations--retrospective and claims database studies
R G Arnold, J G Kotsanos
American Journal of Public Health
|
September 11, 1992
Trend in suicide rates since fluoxetine introduction
D N Masica, J G Kotsanos, C M Beasley, et al.
Pharmacoeconomics
|
April 8, 1992
Clinical economics: a method for prospective health resource data collection
C Copley-Merriman, L Egbuonu-Davis, J G Kotsanos, et al.
Medical Care
|
April 27, 1999
Direct medical charges associated with myocardial infarction in patients with and without diabetes
T L Smith, C A Melfi, J A Kesterson, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
Diabetes, Obesity & Metabolism
|
February 28, 2001
Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro
E J Bastyr, Y Huang, R L Brunelle, et al.
Medical Care
|
April 27, 1999
Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire
W Shen, J G Kotsanos, W J Huster, et al.
The American Journal of Managed Care
|
April 7, 1997
Resource utilization and work or school loss reported by patients with diabetes: experience in diabetes training programs
J C Licciardone, J G Kotsanos, V Brinkman-Kaplan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The Joint Commission Journal on Quality Improvement
|
March 1, 1997
Development of performance measures for seven chronic diseases. Health Outcomes Work Group of the Pharmaceutical Research and Manufacturers of America
J G Kotsanos
The New England Journal of Medicine
|
January 12, 1995
Cost-effectiveness analyses
H Tilson, J G Kotsanos
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 6, 2006
Panel 3: methodological issues in conducting pharmacoeconomic evaluations--retrospective and claims database studies
R G Arnold, J G Kotsanos
American Journal of Public Health
|
September 11, 1992
Trend in suicide rates since fluoxetine introduction
D N Masica, J G Kotsanos, C M Beasley, et al.
Pharmacoeconomics
|
April 8, 1992
Clinical economics: a method for prospective health resource data collection
C Copley-Merriman, L Egbuonu-Davis, J G Kotsanos, et al.
Medical Care
|
April 27, 1999
Direct medical charges associated with myocardial infarction in patients with and without diabetes
T L Smith, C A Melfi, J A Kesterson, et al.
Neuroepidemiology
|
January 1, 1996
Analysis of mortality in pergolide-treated patients with Parkinson's disease
M E Sayler, J S Street, J C Bosomworth, et al.
Diabetes, Obesity & Metabolism
|
February 28, 2001
Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro
E J Bastyr, Y Huang, R L Brunelle, et al.
Medical Care
|
April 27, 1999
Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire
W Shen, J G Kotsanos, W J Huster, et al.
The American Journal of Managed Care
|
April 7, 1997
Resource utilization and work or school loss reported by patients with diabetes: experience in diabetes training programs
J C Licciardone, J G Kotsanos, V Brinkman-Kaplan, et al.
Page
of 2